StockData
MindWalk Holdings Corp. logo

MindWalk Holdings Corp. (HYFT) stock

HYFTNasdaqPharmaceutical PreparationsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 20-F on Jul 23, 2026Score 7/30
$0.68−0.11 (-14.27%)

Close on Nov 20, 2026Market cap $31.97MP/E –Yield –

MindWalk gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

MindWalk's gross profit for the twelve months ending Jul 31, 2026 was C$9.87M, up 57.9% year over year. For fiscal 2026 it was C$9.15M, up 59.6% from the year before. The highest annual figure on record is C$11.56M in fiscal 2023.

Annual gross profit

PeriodPeriod endValueChange
FY2026Apr 30, 2026C$9.15M+59.6%
FY2025Apr 30, 2025C$5.73M+40.1%
FY2024Apr 30, 2024C$4.09M-64.6%
FY2023Apr 30, 2023C$11.56M+5.3%
FY2022Apr 30, 2022C$10.98M-4.8%
FY2021Apr 30, 2021C$11.54M+43.6%
FY2020Apr 30, 2020C$8.03M–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026C$2.25M+47.1%
Q4 FY2026CQ1 2026Apr 30, 2026C$2.50M+56.7%
Q3 FY2026CQ4 2025Jan 31, 2026C$2.46M+39.9%
Q2 FY2026CQ3 2025Oct 31, 2025C$2.66M+94.4%
Q1 FY2026CQ2 2025Jul 31, 2025C$1.53M+51.2%
Q4 FY2025CQ1 2025Apr 30, 2025C$1.59M–
Q3 FY2025CQ4 2024Jan 31, 2025C$1.76M-44.9%
Q2 FY2025CQ3 2024Oct 31, 2024C$1.37M-53.7%
Q1 FY2025CQ2 2024Jul 31, 2024C$1.01M-63.9%
Q4 FY2024CQ1 2024Apr 30, 2024-C$4.85M-245.3%
Q3 FY2024CQ4 2023Jan 31, 2024C$3.20M+7.9%
Q2 FY2024CQ3 2023Oct 31, 2023C$2.95M+6.3%
Q1 FY2024CQ2 2023Jul 31, 2023C$2.80M–
Q4 FY2023CQ1 2023Apr 30, 2023C$3.34M–
Q3 FY2023CQ4 2022Jan 31, 2023C$2.96M–
Q2 FY2023CQ3 2022Oct 31, 2022C$2.78M–

More MindWalk figures

See a number that looks wrong?